Jointly Provided by Med-IQ and the District of Columbia Department of Health.
Glenn Wortmann, MD, FIDSA, FACP
Section Director, Infectious Diseases
MedStar Washington Hospital Center
Rebecca L. Julian, MS, ELS
Senior Manager, Editorial
Stephanie Larson, PhD
Clinical Content Manager
Jacqueline Reuben, MHS
Senior Infectious Disease Epidemiologist
Center for Policy, Planning and Evaluation (CPPE)
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
East Lansing, MI
Jennifer Thomas, PharmD
Medication Safety, Immunizations, Antibiotic Stewardship, DC QIO
Atlantic Quality Innovation Network – District of Columbia
Upon completion, participants should be able to:
- Describe best practice management of asymptomatic bacteriuria
This activity is intended for physicians, nurses, and pharmacists.
Statement of Need
Antimicrobial resistance has been identified by the Centers for Disease Control and Prevention and the World Health Organization as a major threat to public health. Each year in the United States, at least 2 million people develop antibiotic-resistant infections, and at least 23,000 die from complications associated with these infections. Healthcare providers play a key role in protecting patients and preventing infections; therefore, they must be knowledgeable about antimicrobial resistance, resistant infections, and the appropriate treatment of such infections.
Joint Providership Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Med-IQ and the District of Columbia Department of Health. Med-IQ is accredited by the ACCME to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Med-IQ is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This nursing activity has been approved for up to 0.25 contact hour.
Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.25 contact hour (0.025 CEU) of credit for pharmacists. ACPE # 0476-9999-18-005-H01-P. This knowledge-based activity is designed for all pharmacists.
Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Medium/Method of Participation
This CME/CE/CPE activity consists of a 0.25-credit online publication. To receive credit, read the introductory CME/CE/CPE material, read the publication, and complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: December 21, 2018
Expiration Date: December 20, 2019
Estimated Time to Complete This Activity: 15 minutes
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Glenn Wortmann, MD, FIDSA, FACP
Fees received for promotional/non-CME activities: Astellas Pharma, US Inc.
The peer reviewers and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email firstname.lastname@example.org.
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Google Chrome - latest version
Apple Safari - latest version
Adobe Acrobat Reader® or Adobe Reader
Adobe Flash Player
Adobe Flash Player 9 or later
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support.
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Decision-IQ: A Case Study in Acute Sinusitis
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.